Impact of iron overload on interleukin-10 levels, biochemical parameters and oxidative stress in patients with sickle cell anemia

Revista Brasileira de Hematologia e Hemoterapia

Volumn 35, Issue 1, 2013, Pages 29-34

  Barbosa, Maritza Cavalcante ^a   dos Santos, Talyta Ellen Jesus ^a   de Souza, Geane Félix ^a   de Assis, Lívia Coêlho ^a   Freitas, Max Victor Carioca ^a   Gonçalves, Romélia Pinheiro ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Anemia; Interleukin 10; Iron overload; Nitric oxide metabolism; Oxidative stress; Sickle cell

Indexed keywords

EID: 84876026708     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.5581/1516-8484.20130011     Document Type: Article

References (40)

1. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21(1):37-47.
2. Bonini-Domingos CR. Metodologias laboratoriais para o diagnóstico de hemoglobinopatias e talassemias. Brasil: HN; 2006. 121 p.
3. Conran N, Franco-Penteado CF, Costa FF. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion. Hemoglobin. 2009;33(1):1-16.
4. Makis AC, Hatzimichael EC, Bourantas KL. The role of cytokines in sickle cell disease. Ann Hematol. 2000;79(8):407-413.
5. Lanaro C, Franco-Penteado CF, Albuqueque DM, Saad ST, Conran N, Costa FF. Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy. J Leukoc Biol. 2009;85(2):235-242.
6. Moore KM, Vieira P, Fiorentino DF, Tronustine ML, Khan TA, Mosmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science. 1990;248(4960):1230-1234. Erratum in: Science 1990;250(4980):494.
7. Yssel H, De Waal Malefyt R, Roncarolo MG, Abrams JS, Lahesmaa R, Spits H, et al. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol. 1992;149(7):2378-2384.
8. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol. 1993;11:165-190.
9. Bourantas KL, Dalekos GN, Makis A, Chaidos A, Tsiara S, Mavridis A. Acute phase proteins and interleukins in steady state sickle cell disease. Eur J Haematol. 1998;61(1):49-54.
10. Graido-Gonzalez E, Doherty JC, Bergreen EW, Organ G, Telfer M, McMillen MA. Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis. Blood. 1998;92(7):2551-2555.
11. Rees DC, Williams TN, Gladwin NT. Sickle-cell disease. Lancet. 2010;376(9757):2018-2031.
12. Inati A, Khoriaty E, Musallam KM. Iron in sickle-cell disease: what have we learned over the years? Pediatr Blood Cancer. 2011;56(2):182-190.
13. Fung EB, Harmatz P, Milet M, Ballas SK, De Castro L, Hagar W, Owen W, Olivieri N, Smith-Whitley K, Darbari D, Wang W, Vichinsky E; Multi-Center Study of Iron Overload Research Group. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: a report from the multi-center study of iron overload. Am J Hematol. 2007;82(4):255-265.
14. Porter JB. Practical management of iron overload. Br J Haematol. 2001;115(2):239-252.
15. Ward R. An update on disordered iron metabolism and iron overload. Hematology. 2010;15(5):311-317.
16. Ferreira AL, Matsubara LS. Radicais livres: conceitos, doenças relacionadas, sistema de defesa e estresse oxidativo. Rev Assoc Med Bras. 1997;43(1):61-68.
17. Cançado RD. Sobrecarga e quelação de ferro na anemia falciforme. Rev Bras Hematol Hemoter. 2007;29(3):316-326.
18. Draper HH, Hadley M. Malondialdehyde determination as index of lipid pero-xidation. Methods Enzymol. 1990;186:421-431.
19. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and (15N) nitrate in biological fuids. Anal Biochem. 1982;126(1):131-138.
20. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-6.
21. Fillet G, Beguin Y, Baldelli L. Model of reticuloendothelial iron metabolism in humans: Abnormal behavior in idiopathic hemochromatosis and in inflammation. Blood. 1989;74(2):844-851.
22. Olynyk JK, Trinder D, Ramm GA, Britton RS, Bacon BR. Hereditary hemochromatosis in the post HFE era. Hepatology. 2008;48(3):991-1001.
23. Gianini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ. 2005;172(3):367-379.
24. Núñez-Quintana A, Hondal-Álvarez NI, Ayllón-Valdés L. Alteraciones renales en la drepanocitosis. Rev Cub Hematol Inmunol Hemot. 2011;27(2):168-178.
25. Cumming V, King L, Fraser R, Serjeant G, Reid M. Venous incompetence, poverty and lactate dehydrogenase in Jamaica are important predictors of leg ulceration in sickle cell anaemia. Br J Haematol. 2008;142(1):119-125.
26. Kato GJ, McGowan V, Machado RF, Little JA, Taylor J 6th, Morris CR, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood. 2006;107(6):2279-2285.
27. Naoum FA. Alterações do perfl lipídico nas anemias. Rev Bras Hematol Hemoter. 2005;27(3):223-226.
28. Rahimi Z, Merat A, Haghshenass M, Madani H, Rezaei M, Nagel RL. Plasma lipids in Iranians with sickle cell disease: hypocholesterolemia in sickle cell anemia and increase of HDL-cholesterol in sickle cell trait. Clin Chim Acta. 2006;365(1-2):217-220.
29. Oztas Y, Durukan I, Unal S, Ozgunes N. Plasma protein oxidation is correlated positively with plasma iron levels and negatively with hemolysate zinc levels in sickle-cell anemia patients. Int J Lab Hematol. 2012;34(2):129-135.
30. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokines synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 1991;174(5):1209-1220.
31. Jison ML, Munson PJ, Barb JJ, Suffredini AF, Talwar S, Logun C, et al. Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood. 2004;104(1):270-280.
32. Manfredini V, Lazzaretti LL, Griebeler IH, Santin AP, Brandao VD, Wagner S, et al Blood antioxidant parameters in sickle cell anemia patients in steady state. J Natl Med Assoc. 2008;100(8):897-902.
33. Wood KC, Granger DN. Sickle cell disease: role of reactive oxygen and nitrogen metabolites. Clin Exp Pharmacol Physiol. 2007;34(9):926-932.
34. Hundekar P, Suryakar A, Karnik A, Ghone R, Vasaikar M. Antioxidant status and lipid peroxidation in sickle cell anaemia. Biomed Res. 2010;21(4):461-464.
35. Elias DB, Freitas RM, Gonçalves RP, Magalhães HY, Sousa JH, Magalhães SM. Evaluation of the concentration of malondialdehyde and nitrite in patients with sickle cell anemia treated or not with hydroxyurea einstein (São Paulo). 2010;8(4 pt 1):414-418.
36. Hebbel RP, Eaton JW, Balasingam M, Steinberg MH. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest. 1982;70(6):1253-1259.
37. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. Comment in: JAMA. 2005;294(19):2432-2433; author reply 2433-4; JAMA. 2005;294(19):2433; author reply 2433-4.
38. Gonçalves RP, Elias DB, Magalhães HI, de Souza JH. Study of correlation of nitrite levels with malonaldehyde and the prognosis of patients with sickle cell disease on hydroxyurea, Ceará-Brazil. J Clin Lab Anal. 2011;25(5):369-373.
39. Alsultan AL, Seif MA, Aminn TT, Naboli M, Alsuliman AM. Relationship between oxidative stress, ferritin and insulin resistance in sickle cell disease. Eur Rev Med Pharmacol Sci. 2010;14(6):527-538.
40. Wood KC, Hsu LL, Gladwin MT. Sickle cell disease vasculopathy: A state of nitric oxide resistance. Free Radic Biol Med. 2008;44(8):1506-1528.